Combining the results from in vitro and in vivo experiments, our research indicated Piezo1 activation under hyperglycemia and its adverse role in high glucose-induced oxidative stress injury, offering new insights into endothelial dysfunction in hyperglycemia. The gene discussed is PIEZO1; the disease is endothelial dysfunction.